Beckman Coulter Life Sciences is taking actions in the best interests of our associates, customers, and business partners as we navigate the growing threats of the 2019 Novel Coronavirus disease (COVID-19). Learn more
Cellular immunotherapy modifies a person's immune cells (e.g., through genetic engineering or modulating protein expression profile) before reintroducing them back into the body for therapeutic purposes. For example, T-cells can be isolated directly from a patient and then modified in a research laboratory to express receptors targeting cancer cell-specific antigens. These modified T-cells are then allowed to multiply in incubators, after which they are reintroduced in large numbers back into the patient to seek out cancer cells for immune-mediated elimination.2
1. Z. Tao, et al., "Cellular immunotherapy of cancer: an overview and future directions," Immunotherapy 9(7):589-606, 2017.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.